Greater China Junior Stocks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Greater China Junior Stocks

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: manny t who wrote (1050)	12/26/2005 12:06:22 AM
From: manny t	of 1992

AXJ, A little speculation from the same MSGI on IHub: "Wade, the revenues/profits are mind boggling. Lets say that they only get 5% of the 90 mil people in Asia that have diabetes to take their drug (4.5 mil people). Lets also say the pills only cost 10 cents per tablet and you only take one per day. Thats 90 tablets per quarter at 10 cents apiece is $9 per person per quarter. That is about $40 mil per quarter in revenue. If margins are about 40% that is $16 mil per quarter profit. With 20 mil shares OS, that is 80 cents per quarter profit or $3.20 per year profit. At a PE of 20, that is $64 per share. Now I have heard figures of 25 cents per tablet. And what if they get 10% of the 90 mil to take the drug? What if they sell the drug in Europe and North America? What if you have to take 3 tablets per day instead of one? The figures then become mind boggling."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next